52
NO. 3 OF 2020
- (b) to take any steps and implement any measures that the direction may specify, and report to the Director on the steps taken or measures implemented so as to—
- (i) prevent the occurrence or recurrence of any prescribed adverse event; or
- (ii) implement any recommendation of the quality assurance committee to improve the quality of the licensable healthcare service provided by the section 25 licensee.
(3) A direction given under subsection (1) may relate to a service review committee appointed by a section 25 licensee, and require the licensee—
- (a) to require the service review committee to conduct a further evaluation of any trend or pattern of events identified by that committee in connection with the section 25 licensee’s provision of a licensable healthcare service, or undertaking of a programme in relation to the provision of a licensable healthcare service, that does not comply with any prescribed service requirements or code of practice applicable to that licensable healthcare service or programme, as the case may be; or
- (b) to take any steps and implement any measures that the direction may specify, and to report to the Director on the steps taken or measures implemented so as to—
- (i) prevent the occurrence or recurrence of any event that does not comply with any prescribed service requirements or code of practice applicable to any licensable healthcare service or programme (as the case may be) that the service review committee is appointed for; or
- (ii) ensure that the section 25 licensee complies with the prescribed service requirements or code of practice mentioned in sub-paragraph (i).
